Skip to main content

Test Price

1,000 AED

✅ Home Collection Available

Ganciclovir Resistance Detection Test in UAE | 1,000 AED | DHA Licensed

Executive Summary & Core Metrics

  • 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited processing ensures reliable antiviral resistance genotyping.
  • Premium Home Collection – Hospital‑grade cold‑chain logistics, VIP mobile phlebotomy, 8 AM–11 PM daily.
  • Post‑Test Clinical Guidance – Telephonic expert interpretation of results integrated with patient history.
  • Direct Insurance Billing – Verify coverage instantly via WhatsApp at +971 54 548 8731.
  • Test Price: 1,000 AED (all‑inclusive, home collection fee waived).

Test Overview & Methodology

This advanced PCR sequencing assay identifies acquired mutations in cytomegalovirus (CMV) UL97 and UL54 genes, empowering UAE clinicians to precisely tailor antiviral therapy and overcome ganciclovir resistance. The assay amplifies viral DNA from a refrigerated EDTA whole blood sample and uses Sanger sequencing to pinpoint specific resistance‑conferring mutations, helping clinicians adjust therapy to a more effective antiviral agent.

Test Comparison Our Test – PCR Sequencing Phenotypic Antiviral Susceptibility
Precision / Method 99.9% analytical sensitivity; Sanger‑based mutation detection Plaque reduction assay; variable sensitivity (~95%)
Clinical Actionability Identifies specific UL97/UL54 resistance mutations for drug selection Provides only phenotypic IC50 values; limited mutation detail
Turnaround Time 10–12 days 14–21 days; limited laboratory availability

Physician Insight & Safety Protocols

From Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403):

“Understanding your CMV antiviral resistance profile is crucial for tailoring effective therapy, especially in immunocompromised patients. This test provides a molecular blueprint, but it must always be interpreted alongside your full clinical picture—never discontinue prescribed medication without consulting your doctor. If you experience any alarming signs such as sudden vision loss, severe abdominal pain, or confusion, seek immediate medical attention.”

Safety Measures & Clinical Guidance

⚠️ Medication Warning

Your prescribed antiviral therapy should not be altered without direct consultation with your managing clinician. The resistance profile provided by this test is intended to inform, not override, your doctor's clinical judgment.

Exclusion Criteria & ER Red Flags

  • Not applicable for patients without documented CMV infection or who are not currently on antiviral therapy.
  • Sample must be collected and shipped refrigerated (DO NOT FREEZE).
  • Individuals with unstable vital signs, acute sepsis, or suspected end‑organ damage should be urgently evaluated before scheduling a home collection.
  • ER Red Flags: Sudden vision loss (CMV retinitis), severe abdominal tenderness, confusion, or signs of septic shock warrant immediate hospital assessment.

UAE Regulatory & Data Privacy Adherence

This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is the Ganciclovir Resistance Detection test?

PCR sequencing detects UL97 and UL54 gene mutations causing ganciclovir resistance, enabling tailored antiviral treatment decisions. The assay amplifies viral DNA from a blood sample and uses Sanger sequencing to pinpoint specific resistance‑conferring mutations, helping clinicians adjust therapy to a more effective antiviral agent.

2. When should I have this test done?

When CMV viral load increases on ganciclovir, resistance testing identifies mutations, enabling prompt therapy modification. This is particularly critical for transplant recipients, HIV/AIDS patients, and others with immunosuppression who show clinical or virological failure while on maintenance ganciclovir.

3. How is the sample collected and what are the pre‑requirements?

A refrigerated 4 mL EDTA whole blood sample is required; no fasting or special preparation needed. The sample is drawn by a certified phlebotomist during home collection, placed in a cold‑chain container, and transported to the laboratory. Ensure the tube is not frozen and avoid any additional additives.

Clinical & Logistical Metadata

Test Name Ganciclovir Resistance Detection
Price (AED) 1,000
Turnaround Time 10–12 business days
Sample Type / Matrix Refrigerated EDTA whole blood
Methodology Used PCR sequencing (Sanger sequencing)
ICD-10-CM Code B25.9
LOINC Code 101184-0
DHA Facility License & Laboratory Address Invariants 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

Licensed by DHA Facility No. 1143 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139 | UAE PDPL Compliant

Support: +971 54 548 8731 | All clinical content reviewed by DHA‑licensed physician. © 2026

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians